Login

Insider Transactions

What CAS MEDICAL SYSTEMS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Edwards Lifesciences Holding, Inc. 10% owner Apr 18 Other Transaction · J +40,049,789 — — 40,049,789
Patton Thomas M President and CEO Apr 18 Disposition to Issuer · D −150,000 — — 0
Patton Thomas M President and CEO Apr 18 Disposition to Issuer · D −930,889 $2.45 −$2.28M 150,000
Weisshaar Kenneth R Director Apr 18 Disposition to Issuer · D −70,303 $2.45 −$172K 0
Thomas, McNerney & Partners Ii L.p. 10% owner Apr 18 Disposition to Issuer · D −119,872 $2.45 −$294K 0
Thomas, McNerney & Partners Ii L.p. 10% owner Apr 18 Disposition to Issuer · D −43,944 $2.45 −$108K 0
Thomas, McNerney & Partners Ii L.p. 10% owner Apr 18 Disposition to Issuer · D −12,300,186 $2.45 −$30.1M 0
Thomas, McNerney & Partners Ii L.p. 10% owner Apr 18 Derivative Conversion · C +40,772 $2.39 +$97.4K 119,872
Thomas, McNerney & Partners Ii L.p. 10% owner Apr 18 Derivative Conversion · C +3,906,315 $2.39 +$9.33M 12,300,186
Thomas, McNerney & Partners Ii L.p. 10% owner Apr 18 Derivative Conversion · C +71,075 $2.39 +$170K 79,100
Thomas, McNerney & Partners Ii L.p. 10% owner Apr 18 Derivative Conversion · C +24,125 $2.39 +$57.6K 30,063
Thomas, McNerney & Partners Ii L.p. 10% owner Apr 18 Derivative Conversion · C +6,802,834 $2.39 +$16.3M 8,393,871
Tune Kathleen A Director Apr 18 Disposition to Issuer · D −63,454 $2.45 −$155K 0
Benni Paul Chief Scientific Officer Apr 18 Disposition to Issuer · D −177,379 $2.45 −$435K 0
Gamelin John Vice President, R&D Apr 18 Disposition to Issuer · D −186,078 $2.45 −$456K 0
Thomas, McNerney & Partners Ii L.p. 10% owner Apr 18 Derivative Conversion · C +13,881 $2.39 +$33.2K 43,944
Milinazzo Alan Director Apr 18 Disposition to Issuer · D −42,500 $2.45 −$104K 0
Rainey Gregory P Director Apr 18 Disposition to Issuer · D −70,431 $2.45 −$173K 0
Thomas James E Director Apr 18 Disposition to Issuer · D −63,454 $2.45 −$155K 0
Molloy Paul A Director Apr 18 Disposition to Issuer · D −42,500 $2.45 −$104K 0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support